This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MABTECH
product type :
ELISA/assay
product name :
Human apoB ELISA development kit (ALP)
catalog :
3715-1A-20
quantity :
for 20 plates
price :
555 USD
citations: 6
| Reference |
|---|
product information
Product Code :
3715-1A-20
Product Name :
Human apoB ELISA development kit (ALP)
Categories :
ELISA Kits
Size :
for 20 plates
Size Number :
for 20
Size Unit :
plates
EUR :
555
USD :
555 USD
GBP :
400
AUD :
880
SEK :
4530
Enzyme/Conjugate :
ALP
Format :
without plates
Kit Detection Type :
Streptavidin-ALP
Application :
ELISA
Reactivities :
human, non-human primates
Analytes :
apoB
Complementary Products :
3652-M2, 3652-P10
Recommended Products :
3715-1H-20, 3715-1HP-10, 3710-1HP-10, 3714-1HP-10, 3712-1HP-10, 3711-1HP-10, 3713-1HP-10
Contents :
Capture mAb (LDL 20/17),Biotinylated detection mAb (LDL 11),Streptavidin-ALP,Human apoB ELISA standard
Product Header :
ELISA development kit for quantification of apoB in solution
Description 1 :
The apoB ELISA development kit is ideal for users who want the flexibility of setting up their own ELISA assay. This product enables quantification of apoB in solution, e.g. in cell culture supernatants. The assay is specific for apoB100 and does not recognize apoB48. The kit contains a matched pair of monoclonal capture and detection antibodies, Streptavidin-ALP and ELISA standard. Plates and substrate are not included.
Description 2 :
ApoB ELISA development kits are also available with Streptavidin-HRP.
Species Cross Reactivities :
The monoclonal antibodies in this kit cross-react with ApoB from non-human primates.
Standard range :
8-800 ng/ml
References :
Vu, C. B., et al. (2016). Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid. Journal of Medicinal Chemistry. (http://www.ncbi.nlm.nih.gov/pubmed/26784936)
Yu, H., et al. (2019). GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis. Cell. (http://www.ncbi.nlm.nih.gov/pubmed/31778654)
Derwall, M., et al. (2012). Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. (http://www.ncbi.nlm.nih.gov/pubmed/22223731)
Cayo, M. A., et al. (2017). A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. Cell Stem Cell. (http://www.ncbi.nlm.nih.gov/pubmed/28388428)
Bissig-Choisat, B., et al. (2015). Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nature Communications. (http://www.ncbi.nlm.nih.gov/pubmed/26081744)
Shelf Life :
18 months
Last updated :
2013-07-01
company information

MABTECH
Box 1233
SE-131 28 Nacka Strand
SE-131 28 Nacka Strand
mabtech@mabtech.com
http://www.mabtech.com1 866 354-7768
headquarters: Sweden
questions and comments
